data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Radius Health
(NASDAQ:RDUS)
10.11
-0.73[-6.73%]
At close: Jun 24
10.07
-0.0400[-0.40%]
After Hours: 7:22PM EDT
Day High/Low10.06 - 10.84
52 Week High/Low4.97 - 23
Open / Close10.77 / 10.11
Float / Outstanding27.3M / 47.6M
Vol / Avg.5.3M / 1.1M
Mkt Cap481.2M
P/E-
50d Avg. Price6.94
Div / Yield-
Payout Ratio-
EPS-0.39
Total Float27.3M

Radius Health (NASDAQ:RDUS), Quotes and News Summary

Radius Health (NASDAQ: RDUS)

Day High/Low10.06 - 10.84
52 Week High/Low4.97 - 23
Open / Close10.77 / 10.11
Float / Outstanding27.3M / 47.6M
Vol / Avg.5.3M / 1.1M
Mkt Cap481.2M
P/E-
50d Avg. Price6.94
Div / Yield-
Payout Ratio-
EPS-0.39
Total Float27.3M
Benzinga - 2 days ago
Benzinga - 2 days ago
Benzinga - 2 days ago
Benzinga - 3 days ago
Benzinga - 3 days ago
Benzinga - 3 days ago
Benzinga - Jun 16, 2022, 9:04AM
Benzinga - Jun 8, 2022, 8:59AM
Benzinga - Jun 8, 2022, 8:04AM
Benzinga - Jun 6, 2022, 9:03AM
Benzinga - Jun 1, 2022, 4:24PM
Benzinga - May 24, 2022, 10:44AM
Benzinga - May 24, 2022, 10:19AM
Benzinga - May 23, 2022, 4:57AM
Benzinga - May 20, 2022, 9:46AM
Benzinga - May 19, 2022, 5:02PM
Benzinga - May 5, 2022, 7:41AM
Benzinga - Mar 16, 2022, 8:32AM
Benzinga - Mar 8, 2022, 8:36AM
Benzinga - Mar 1, 2022, 8:18AM
Benzinga - Feb 24, 2022, 7:47AM
load more
Sector: Health Care.Industry: Biotechnology
Radius Health Inc is an integrated biopharmaceutical company. It develops and commercializes endocrine therapeutics in the areas of osteoporosis and oncology. The company's product, TYMLOS, is for the treatment of postmenopausal women with osteoporosis at high risk for fracture, defined as a history of osteoporotic fracture, multiple risk factors for fracture, or patients who have failed or are intolerant to other available osteoporosis therapy. The product pipeline of the company includes Abaloparatide-patch for the treatment of postmenopausal women with osteoporosis, Elacestrant, and RAD140. It primarily operates the business in the United States of America and generates key revenue from the sales of TYMLOS.
Read More

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-04
REV
Q1 2022Est.ActualSurprise
EPS-0.210-0.390 -0.1800
REV51.290M43.158M-8.132M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Radius Health Questions & Answers

Q
How do I buy Radius Health (RDUS) stock?
A

You can purchase shares of Radius Health (NASDAQ: RDUS) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Radius Health's (RDUS) competitors?
Q
What is the target price for Radius Health (RDUS) stock?
A

The latest price target for Radius Health (NASDAQ: RDUS) was reported by SVB Leerink on Friday, June 24, 2022. The analyst firm set a price target for 10.00 expecting RDUS to fall to within 12 months (a possible -1.09% downside). 15 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Radius Health (RDUS)?
A

The stock price for Radius Health (NASDAQ: RDUS) is $10.11 last updated June 24, 2022, 8:00 PM UTC.

Q
Does Radius Health (RDUS) pay a dividend?
A

There are no upcoming dividends for Radius Health.

Q
When is Radius Health (NASDAQ:RDUS) reporting earnings?
A

Radius Health’s Q2 earnings are confirmed for Thursday, August 4, 2022.

Q
Is Radius Health (RDUS) going to split?
A

There is no upcoming split for Radius Health.

Q
What sector and industry does Radius Health (RDUS) operate in?
A

Radius Health is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.